SCHEMBL6078239

SCHEMBL6078239

Cc1cc(Cl)ccc1-c1nsnc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.42
HSP90AB1 P08238 1/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
CRHR1 P34998 2/20 0.38
CASP3 P42574 1/20 0.38
HSD11B1 P28845 1/20 0.36
CYP3A4 P08684 1/20 0.34
CHRM1 P11229 1/20 0.34
GRM2 Q14416 1/20 0.34
SCN9A Q15858 3/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29719717 0.73 NOTUM (0.53) NOTUMCASP3HSD11B1CYP3A4GRM2
SCHEMBL6079053 0.70 NOTUM (0.41) NOTUMHSP90AB1KDM4EALDH1A1MAPT
SCHEMBL7611053 0.70 MPI (0.41) CYP3A4CYP2A6
SCHEMBL12071484 0.69 NOTUM (0.50) NOTUMHSP90AB1CASP3HSD11B1CYP3A4
SCHEMBL4709705 0.69 NOTUM (0.47) NOTUMHSP90AB1MAPTHPGDNPSR1
SCHEMBL12496840 0.69 CASP3 (0.42) NOTUMHSP90AB1CRHR1CASP3HSD11B1
SCHEMBL8935466 0.69 KDM4E (0.41) NOTUMKDM4EALDH1A1MAPTHPGD
SCHEMBL10983827 0.68 IDO1 (0.45) NOTUMKDM4EALDH1A1
SCHEMBL12497465 0.68 CASP3 (0.41) NOTUMHSP90AB1KDM4EALDH1A1CRHR1
SCHEMBL12497363 0.68 NOTUM (0.48) NOTUMHSD11B1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7144899-B2 Thrombin inhibitors MERCK & CO., INC. (US) 2006-12-05 US disclosed
WO-2004032834-A2 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2004-04-22 WO disclosed
US-20040073025-A1 Thrombin inhibitors MERCK SHARP & DOHME CORP. 2004-04-15 US disclosed
WO-2002064559-A2 THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073025-A1 Thrombin inhibitors F2, F11, F10 NOTUM 1633/4885HSP90AB1 3434/4885KDM4E 3151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.